Financial Comparison: Boston Scientific Corporation (BSX) and Mindray Medical International (MR)

Boston Scientific Corporation (NYSE: BSX) and Mindray Medical International (NYSE:MR) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Profitability

This table compares Boston Scientific Corporation and Mindray Medical International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Boston Scientific Corporation 9.55% 23.60% 9.24%
Mindray Medical International 15.93% 12.70% 8.37%

Valuation and Earnings

This table compares Boston Scientific Corporation and Mindray Medical International’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Boston Scientific Corporation $8.39 billion 4.64 $347.00 million $0.61 46.49
Mindray Medical International N/A N/A N/A $1.49 18.75

Boston Scientific Corporation has higher revenue and earnings than Mindray Medical International. Mindray Medical International is trading at a lower price-to-earnings ratio than Boston Scientific Corporation, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

90.5% of Boston Scientific Corporation shares are owned by institutional investors. 0.7% of Boston Scientific Corporation shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dividends

Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Boston Scientific Corporation does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.

Analyst Ratings

This is a summary of current recommendations for Boston Scientific Corporation and Mindray Medical International, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific Corporation 0 4 13 0 2.76
Mindray Medical International 0 0 0 0 N/A

Boston Scientific Corporation presently has a consensus target price of $31.11, suggesting a potential upside of 9.69%. Given Boston Scientific Corporation’s higher probable upside, equities research analysts clearly believe Boston Scientific Corporation is more favorable than Mindray Medical International.

Summary

Boston Scientific Corporation beats Mindray Medical International on 8 of the 11 factors compared between the two stocks.

Boston Scientific Corporation Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Mindray Medical International Company Profile

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply